AmerisourceBergen Corporation – Consensus Indicates Potential 16.4% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 13 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 191 and 150 and has a mean target at 171.92. Now with the previous closing price of 147.76 this would imply there is a potential upside of 16.4%. There is a 50 day moving average of 143.52 while the 200 day moving average is 141.25. The company has a market capitalisation of $31,192m. Company Website: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,293m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 16.4% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 13 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 191 and 150 and has a mean target at 171.92. Now with the previous closing price of 147.76 this would imply there is a potential upside of 16.4%. There is a 50 day moving average of 143.52 while the 200 day moving average is 141.25. The company has a market capitalisation of $31,192m. Company Website: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $36,293m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.